STJ is still expecting revenue growth of 10% on a constant-currency basis, and STJ CRM is still expecting around 5% revenue growth constant currency. BSX has a negative EPS, so to think that BSX is somehow outdoing STJ is absurd. STJ is maintaining their market share against BSX/Guidant and MDT, there is certainly no way that BSX is taking share away from them. Another point to remember is that ABT and STJ have a bundling deal where ABT's coronary stents are bundled with STJ's CRM products, to better compete against BSX and MDT.
Plus, STJ gets to keep the money it earns, BSX has to ship their cash off to JNJ for patent infringement!!!!!!
BSX is kicking MDT and STJ butts, that's why STJ's stock is tanking. By the end of the year, BSX will be the #1 CRM company. STJ and MDT are recalling all their junk devices anyways. STJ will probably become penny stock in a few months and BSX will launch a hostile takeover of them just to dig STJ's grave.
jellviet I wouldn't be so sure that BSX is NOT taking market share from St. Jude CRM. From where I sit it sure appears BSX CRM is taking share and has been all summer. I think the reality of their home monitoring system's inferiority is coming home to roust.
STJ warned this mourning. STJ down 15% and MDT and BSX down in sympathy.
I've listened to the last few cc and investor presentations Ray Elliot and company have made. They keep talking about taking market share in CRM. Could this be one of the reasons STJ warned and may this actually turn out to be a positive for BSX. I guess we'll see at the end of the month with the next earnings report. GLTA